Comparison of CpG Island Methylator Phenotype (CIMP) Frequency in Colon Cancer Using Different Probe- and Gene-Specific Scoring Alternatives on Recommended Multi-Gene Panels

被引:29
作者
Berg, Marianne [1 ,2 ]
Hagland, Hanne R. [1 ]
Soreide, Kjetil [1 ,3 ]
机构
[1] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway
[2] Univ Stavanger, Ctr Organelle Res, Stavanger, Norway
[3] Univ Bergen, Dept Clin Med, Bergen, Norway
关键词
COLORECTAL-CANCER; DNA TEST; EPIGENETICS; MARKERS; EPIGENOTYPES; BIOMARKERS; ASSAY; MLPA;
D O I
10.1371/journal.pone.0086657
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: In colorectal cancer a distinct subgroup of tumours demonstrate the CpG island methylator phenotype (CIMP). However, a consensus of how to score CIMP is not reached, and variation in definition may influence the reported CIMP prevalence in tumours. Thus, we sought to compare currently suggested definitions and cut-offs for methylation markers and how they influence CIMP classification in colon cancer. Methods: Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), with subsequent fragment analysis, was used to investigate methylation of tumour samples. In total, 31 CpG sites, located in 8 different genes (RUNX3, MLH1, NEUROG1, CDKN2A, IGF2, CRABP1, SOCS1 and CACNA1G) were investigated in 64 distinct colon cancers and 2 colon cancer cell lines. The Ogino gene panel includes all 8 genes, in addition to the Weisenberger panel of which only 5 of the 8 genes included were investigated. In total, 18 alternative combinations of scoring of CIMP positivity on probe-, gene-, and panel-level were analysed and compared. Results: For 47 samples (71%), the CIMP status was constant and independent of criteria used for scoring; 34 samples were constantly scored as CIMP negative, and 13 (20%) consistently scored as CIMP positive. Only four of 31 probes (13%) investigated showed no difference in the numbers of positive samples using the different cut-offs. Within the panels a trend was observed that increasing the gene-level stringency resulted in a larger difference in CIMP positive samples than increasing the probe-level stringency. A significant difference between positive samples using 'the most stringent' as compared to 'the least stringent' criteria (20% vs 46%, respectively; p<0.005) was demonstrated. Conclusions: A statistical significant variation in the frequency of CIMP depending on the cut-offs and genes included in a panel was found, with twice as many positives samples by least compared to most stringent definition used.
引用
收藏
页数:7
相关论文
共 24 条
[1]
Toward a comprehensive and systematic methylome signature in colorectal cancers [J].
Ashktorab, Hassan ;
Rahi, Hamed ;
Wansley, Daniel ;
Varma, Sudhir ;
Shokrani, Babak ;
Lee, Edward ;
Daremipouran, Mohammad ;
Laiyemo, Adeyinka ;
Goel, Ajay ;
Carethers, John M. ;
Brim, Hassan .
EPIGENETICS, 2013, 8 (08) :807-815
[2]
Berg M, INTJMOLSCI, V12, P9426
[3]
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer [J].
deVos, Theo ;
Tetzner, Reimo ;
Model, Fabian ;
Weiss, Gunter ;
Schuster, Matthias ;
Distler, Juergen ;
Steiger, Kathryn V. ;
Gruetzmann, Robert ;
Pilarsky, Christian ;
Habermann, Jens K. ;
Fleshner, Phillip R. ;
Oubre, Benton M. ;
Day, Robert ;
Sledziewski, Andrew Z. ;
Lofton-Day, Catherine .
CLINICAL CHEMISTRY, 2009, 55 (07) :1337-1346
[4]
Epigenetics of Colorectal Cancer [J].
Goel, Ajay ;
Boland, C. Richard .
GASTROENTEROLOGY, 2012, 143 (06) :1442-+
[5]
Molecular Pathways and Cellular Metabolism in Colorectal Cancer [J].
Hagland, Hanne R. ;
Berg, Marianne ;
Jolma, Ingunn W. ;
Carlsen, Arne ;
Soreide, Kjetil .
DIGESTIVE SURGERY, 2013, 30 (01) :12-25
[6]
DNA methylation biomarkers and their utility for solid cancer diagnostics [J].
Heichman, Karen A. ;
Warren, Jorja D. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (10) :1707-1721
[7]
Genome-scale analysis of aberrant DNA methylation in colorectal cancer [J].
Hinoue, Toshinori ;
Weisenberger, Daniel J. ;
Lange, Christopher P. E. ;
Shen, Hui ;
Byun, Hyang-Min ;
Van Den Berg, David ;
Malik, Simeen ;
Pan, Fei ;
Noushmehr, Houtan ;
van Dijk, Cornelis M. ;
Tollenaar, Rob A. E. M. ;
Laird, Peter W. .
GENOME RESEARCH, 2012, 22 (02) :271-282
[8]
Hughes LA, 2013, CANC RES
[9]
Opinion - CpG island methylator phenotype in cancer [J].
Issa, JP .
NATURE REVIEWS CANCER, 2004, 4 (12) :988-993
[10]
Issa JP, 2000, ANN NY ACAD SCI, V910, P140